scholarly article | Q13442814 |
P50 | author | Steven Nissen | Q7615086 |
Sankar Navaneethan | Q109544900 | ||
Stacy Brethauer | Q114426598 | ||
Deepak L. Bhatt | Q47264894 | ||
John P Kirwan | Q88081798 | ||
P2093 | author name string | Kathy Wolski | |
Sangeeta R Kashyap | |||
STAMPEDE Investigators | |||
Ali Aminian | |||
Claire E Pothier | |||
Esther S H Kim | |||
Philip R Schauer | |||
P2860 | cites work | Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects | Q22250885 |
Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus | Q24535547 | ||
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
Health benefits of gastric bypass surgery after 6 years | Q30542947 | ||
Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus | Q33949927 | ||
Bariatric surgery and long-term cardiovascular events. | Q34030064 | ||
Bariatric surgery versus conventional medical therapy for type 2 diabetes | Q34263754 | ||
Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up | Q34583219 | ||
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis | Q34660044 | ||
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V | Q34748094 | ||
Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review | Q34757695 | ||
Bariatric surgery: an IDF statement for obese Type 2 diabetes | Q35069674 | ||
Bariatric surgery versus intensive medical therapy in obese patients with diabetes | Q36025669 | ||
Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity | Q36047225 | ||
Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment | Q37022586 | ||
Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. | Q37638200 | ||
Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician. | Q37970042 | ||
Bariatric surgery and cardiovascular outcomes: a systematic review. | Q38053138 | ||
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial | Q38392749 | ||
Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus | Q44609117 | ||
Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. | Q50962089 | ||
The RAND 36-Item Health Survey 1.0. | Q53676093 | ||
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Soci | Q56773058 | ||
Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). | Q64884252 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bariatric surgery | Q357503 |
P304 | page(s) | 2002-2013 | |
P577 | publication date | 2014-03-31 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes | |
P478 | volume | 370 |
Q89017965 | 30-Day Outcomes of Revisional Bariatric Stapling Procedures: First Report Based on MBSAQIP Data Registry |
Q51744766 | A 4-Week Preoperative Ketogenic Micronutrient-Enriched Diet Is Effective in Reducing Body Weight, Left Hepatic Lobe Volume, and Micronutrient Deficiencies in Patients Undergoing Bariatric Surgery: a Prospective Pilot Study. |
Q53196873 | A Challenge between Trainee Education and Patient Safety: Does Fellow Participation Impact Postoperative Outcomes Following Bariatric Surgery? |
Q57171210 | A Longer Biliopancreatic Limb in Roux-en-Y Gastric Bypass Improves Weight Loss in the First Years After Surgery: Results of a Randomized Controlled Trial |
Q48035253 | A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy |
Q53778202 | A Prospective Randomized Controlled Trial of the Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition. |
Q39434406 | A Simple Food-Diverting Operation for Type 2 Diabetes Treatment. Preliminary Results in Humans with BMI 28-32 kg/m2. |
Q26744812 | A Systematic Review and Meta-Analysis of Outcomes for Type 1 Diabetes after Bariatric Surgery |
Q36360575 | A case of severe anorexia, excessive weight loss and high peptide YY levels after sleeve gastrectomy |
Q34103558 | A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease? |
Q47137408 | A novel approach to glycemic control in type 2 diabetes mellitus, partial jejunal diversion: pre-clinical to clinical pathway |
Q35534520 | A novel multidisciplinary intervention for long-term weight loss and glycaemic control in obese patients with diabetes |
Q47903226 | A qualitative study of the role of Australian general practitioners in the surgical management of obesity |
Q47138367 | A working paradigm for the treatment of obesity in gastrointestinal practice |
Q46084030 | ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management |
Q61905346 | ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management |
Q61905355 | ASGE EndoVators Summit: defining the role and value of endoscopic therapies in obesity management |
Q57450753 | ASMBS pediatric metabolic and bariatric surgery guidelines, 2018 |
Q47256071 | Ablation of the Duodenal Mucosa as a Strategy for Glycemic Control in Type 2 Diabetes: Role of Nutrient Signaling or Simple Weight Loss |
Q36060744 | Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice |
Q30360570 | Adults with long-duration type 2 diabetes have blunted glycemic and β-cell function improvements after bariatric surgery. |
Q90396286 | Alterations of Gastric Emptying Features Following Laparoscopic Sleeve Gastrectomy in Chinese Patients with Obesity: a Self-Controlled Observational Study |
Q39434454 | Anaesthetic Preparation of Obese Patients: Current Status on Optimal Work-up |
Q87998343 | Anemia and Bariatric Surgery: Results of a National French Survey on Administrative Data of 306,298 Consecutive Patients Between 2008 and 2016 |
Q37322475 | Application of side-to-side anastomosis of the lesser curvature of stomach and jejunum in gastric bypass |
Q27008820 | Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose? |
Q57394351 | Assessment of mammographic breast density after sleeve gastrectomy |
Q49951864 | Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later |
Q38258985 | Association of race and socioeconomic status with outcomes following laparoscopic Roux-en-Y gastric bypass |
Q34490397 | Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery |
Q87318377 | Balancing risks and benefits of bariatric surgery for type 2 diabetes |
Q35695556 | BariSurg trial: Sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35-60 kg/m(2) - a multi-centre randomized patient and observer blind non-inferiority trial |
Q89004401 | Bariatric Arterial Embolization for Obesity: A Review of Early Clinical Evidence |
Q45934116 | Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 Patients. |
Q35566022 | Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study |
Q33551839 | Bariatric Surgery Prior to Index Screening Colonoscopy Is Associated With a Decreased Rate of Colorectal Adenomas in Obese Individuals |
Q47677805 | Bariatric Surgery Provides a "Bridge to Transplant" for Morbidly Obese Patients with Advanced Heart Failure and May Obviate the Need for Transplantation |
Q36005792 | Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes. |
Q38398940 | Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Second IFSO Global Registry Report 2013-2015. |
Q40229384 | Bariatric Surgery and Kidney-Related Outcomes. |
Q33711409 | Bariatric Surgery and Liver Transplantation |
Q39436582 | Bariatric Surgery and Long-term Durability of Weight Loss |
Q39417384 | Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy |
Q41513392 | Bariatric Surgery for Type 2 Diabetes: Getting Closer to the Long-term Goal |
Q47325007 | Bariatric Surgery in Obese Patients with Type 1 Diabetes: Effects on Weight Loss and Metabolic Control |
Q35875543 | Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care |
Q38960171 | Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes |
Q38572077 | Bariatric Surgery versus Intensive Medical Weight Management for Type 2 Diabetes. |
Q49899707 | Bariatric Surgery: A Perspective for Primary Care |
Q38661024 | Bariatric Surgery: The Future of Obesity Management in Adolescents |
Q38410200 | Bariatric and metabolic surgery: a shift in eligibility and success criteria |
Q60907570 | Bariatric surgery among patients with heart failure: a systematic review and meta-analysis |
Q26783213 | Bariatric surgery and diabetes remission: Who would have thought it? |
Q39085972 | Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies |
Q64262531 | Bariatric surgery and hypertension: implications and perspectives after the GATEWAY randomized trial |
Q91069213 | Bariatric surgery and type 2 diabetes: a step closer to defining an optimal approach |
Q36163431 | Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? |
Q39023968 | Bariatric surgery for obesity and metabolic disorders: state of the art. |
Q37017318 | Bariatric surgery is associated with improvement in kidney outcomes. |
Q50083483 | Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals |
Q42431844 | Bariatric surgery saves lives |
Q35749702 | Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: a cohort study |
Q42795731 | Bariatric surgery: an attractive therapeutic modality for type 2 diabetes mellitus |
Q53344977 | Bariatric surgery: time to move beyond clinical outcomes. |
Q36784484 | Bariatric surgery: traversing the CROSSROADS into mainstream diabetes care |
Q47965626 | Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial |
Q36930271 | Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2 |
Q39145500 | Beneficial Effects of a Dietary Weight Loss Intervention on Human Gut Microbiome Diversity and Metabolism Are Not Sustained during Weight Maintenance |
Q98178564 | Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes |
Q92747716 | Bile Diversion Improves Metabolic Phenotype Dependent on Farnesoid X Receptor (FXR) |
Q39228891 | Bile acids and bariatric surgery |
Q27020976 | Bile acids, obesity, and the metabolic syndrome |
Q35703158 | Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery. |
Q37513457 | Blockade of Central GLP-1 Receptors Deteriorates the Improvement of Diabetes after Ileal Transposition |
Q36911487 | C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery |
Q34680490 | CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY. |
Q60614572 | Cardiac Prevention Guidelines |
Q51743643 | Cardiometabolic Effects of Anti-obesity Pharmacotherapy. |
Q61950936 | Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI |
Q35592620 | Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome |
Q38412110 | Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study |
Q38985963 | Cardiovascular effects of bariatric surgery |
Q38430788 | Cardiovascular, renal and overall health outcomes after bariatric surgery. |
Q48103365 | Central Modulation of Energy Homeostasis and Cognitive Performance After Bariatric Surgery |
Q27331844 | Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies |
Q39076089 | Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study |
Q50430964 | Changes in adiposity and other cardiometabolic risk factors following Roux-en-Y gastric bypass: A 12-month prospective cohort study in Chinese patients |
Q51294308 | Changes in insulin sensitivity and secretion after sleeve gastrectomy. |
Q42174394 | Changes in regional body composition over 8 years in a randomized lifestyle trial: The look AHEAD study |
Q41145464 | Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study |
Q41909990 | Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass. |
Q47332999 | Circulating ANGPTL8/Betatrophin Concentrations Are Increased After Surgically Induced Weight Loss, but Not After Diet-Induced Weight Loss |
Q38572961 | Clinical Management of Type 2 Diabetes Mellitus after Bariatric Surgery |
Q39737868 | Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes |
Q38843881 | Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications |
Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
Q45128866 | Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes |
Q35070830 | Clinician's guide to the updated ABCs of cardiovascular disease prevention |
Q42082791 | Combination therapy with GLP-1 analogues and SGLT-2 inhibitors in the management of diabesity: the real world experience. |
Q86089829 | Comment on: Is glycosylated hemoglobin A1 c associated with increased risk for severe early postoperative complications in nondiabetics after laparoscopic gastric bypass? |
Q89451135 | Comparative Characteristics of Patients with Type 2 Diabetes Mellitus Treated by Bariatric Surgery Versus Medical Treatment: a Multicentre Analysis of 277,862 Patients from the German/Austrian DPV Database |
Q37127390 | Comparative effectiveness and safety of gastric bypass, sleeve gastrectomy and adjustable gastric banding in a population-based bariatric program: prospective cohort study. |
Q57111820 | Comparison of Great Curvature Plication with Duodenal-Jejunal Bypass (GCP-DJB) and Sleeve Gastrectomy (SG) on Metabolic Indices and Gut Hormones in Type 2 Diabetes Mellitus Rats |
Q47738963 | Comparison of Outcomes Between Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in a Lebanese Bariatric Surgical Practice |
Q88034892 | Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents |
Q37717858 | Comparison of consumption behavior and appetite sensations among patients with type 2 diabetes mellitus after bariatric surgery |
Q38211505 | Control of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) study |
Q38358945 | Controversies in bariatric surgery |
Q64248633 | Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand |
Q41136739 | Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S. |
Q90465244 | Current and Future Endoscopic Weight Loss Solutions |
Q56343202 | Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis |
Q47666230 | Customization of bilio-pancreatic limb length to modulate and sustain anti-diabetic effect of gastric bypass surgery |
Q65001046 | De vuelta a la clínica: sin justificación no existe pregunta de investigación que valga. |
Q41040405 | Decreased Cardiovascular Risk after Roux-en-Y Gastric Bypass Surgery in Chinese Diabetic Patients with Obesity |
Q37639541 | Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery. |
Q47558223 | Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia |
Q55398988 | Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metaboli |
Q38812184 | Diabetes after Bariatric Surgery |
Q42248824 | Diabetes recurrence after metabolic surgeries correlates with re-impaired insulin sensitivity rather than beta-cell function |
Q56977501 | Diabetes remission and relapse after metabolic surgery |
Q87686119 | Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy |
Q87845901 | Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter] |
Q38648297 | Diarrhea after bariatric procedures: Diagnosis and therapy. |
Q53765904 | Differences in Anthropometric and Metabolic Parameters Between Subjects with Hypoglycaemia and Subjects with Euglycaemia After an Oral Glucose Tolerance Test Six Months After Laparoscopic Sleeve Gastrectomy. |
Q30277979 | Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery |
Q64233406 | Differential composition of gut microbiota among healthy volunteers, morbidly obese patients and post-bariatric surgery patients |
Q91871803 | Discordance in prediction for prognosis of type 2 diabetes after metabolic surgery: comparison of the ABCD, DiaRem, and individualized metabolic surgery models |
Q33824299 | Distinct patterns in the gut microbiota after surgical or medical therapy in obese patients |
Q38639436 | Do Food Preferences Change After Bariatric Surgery? |
Q55220546 | Does Gastric Surgery (Such as Bariatric Surgery) Impact the Risk of Intestinal Inflammation? |
Q55339136 | Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus? |
Q88747509 | Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model |
Q36068612 | Duodenal stump leak following a duodenal switch: A case report |
Q57104599 | Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model |
Q40696946 | Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial |
Q55497819 | EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. |
Q60462090 | EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease |
Q86872308 | Early Postoperative Outcomes of Primary Bariatric Surgery in Patients on Chronic Steroid or Immunosuppressive Therapy |
Q26824144 | Early onset type 2 diabetes: risk factors, clinical impact and management |
Q47563194 | Effect of Bariatric Surgery on CKD Risk |
Q41117717 | Effect of Early Use of Covered Self-Expandable Endoscopic Stent on the Treatment of Postoperative Stapler Line Leaks |
Q37587252 | Effect of Laparoscopic Sleeve Gastrectomy on Fasting Gastrointestinal, Pancreatic, and Adipose-Derived Hormones and on Non-Esterified Fatty Acids. |
Q50886155 | Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class. |
Q49702411 | Effect of Roux-en-Y Gastric Bypass on the NLRP3 Inflammasome in Pancreatic Islets from Zucker Diabetic Fatty Rats |
Q36405830 | Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on gastrointestinal metabolism of ingested glucose |
Q51299591 | Effect of Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for Type 2 Diabetes Control in an Obese Rat Model. |
Q36327719 | Effect of bariatric surgery on cardiometabolic risk in elderly patients: A population-based study |
Q47387845 | Effect of bariatric surgery on diabetic nephropathy in obese type 2 diabetes patients in a retrospective 2-year study: A local pilot |
Q55046907 | Effect of gastric bypass combined with ileal transportation on type 2 diabetes mellitus. |
Q38625348 | Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis |
Q50125577 | Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study |
Q36639808 | Effectiveness and safety of laparoscopic Roux-en-Y gastric bypass for the treatment of type 2 diabetes mellitus |
Q52660011 | Effectiveness of an Interprofessional Glycemic Optimization Clinic on Preoperative Glycated Hemoglobin Levels for Adult Patients with Type 2 Diabetes Undergoing Bariatric Surgery. |
Q47789013 | Effects of Bariatric Surgery on Change of Brown Adipocyte Tissue and Energy Metabolism in Obese Mice |
Q38780759 | Effects of Bariatric Surgery on Mortality, Cardiovascular Events, and Cancer Outcomes in Obese Patients: Systematic Review and Meta-analysis |
Q48346217 | Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model |
Q35731755 | Effects of an eight-week supervised, structured lifestyle modification programme on anthropometric, metabolic and cardiovascular risk factors in severely obese adults. |
Q58167278 | Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery |
Q89928292 | Efficacy and Safety of Endoscopic Sleeve Gastroplasty at Mid Term in the Management of Overweight and Obese Patients: a Systematic Review and Meta-Analysis |
Q92243626 | Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial |
Q48137462 | Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey. |
Q59043926 | Endogenous Glucagon-Like Peptide-1 as a Potential Mediator of the Resolution of Diabetic Kidney Disease following Roux en Y Gastric Bypass: Evidence and Perspectives |
Q30240029 | Endoscopic Bariatric and Metabolic Therapies: Surgical Analogues and Mechanisms of Action |
Q38817948 | Endoscopic Devices for Obesity |
Q47779748 | Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up |
Q92090714 | Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study |
Q37143824 | Energy restriction and Roux-en-Y gastric bypass reduce postprandial α-dicarbonyl stress in obese women with type 2 diabetes |
Q88669521 | Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor |
Q40436924 | Estimated GFR Before and After Bariatric Surgery in CKD. |
Q47094048 | European Guidelines for Obesity Management in Adults. |
Q57687713 | European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts |
Q91643597 | Evaluation of the Diabetes Regional Coordination Path using the Diabetes Coordination Notebook in community-based diabetes care |
Q46747015 | Expanded indications for bariatric surgery: should patients on chronic steroids be offered bariatric procedures? |
Q40034159 | Experiences of accessing obesity surgery on the NHS: a qualitative study |
Q36425655 | Facilitated long chain fatty acid uptake by adipocytes remains upregulated relative to BMI for more than a year after major bariatric surgical weight loss |
Q38659973 | Factors Associated With Achieving a Body Mass Index of Less Than 30 After Bariatric Surgery |
Q36730322 | Failed Surgical Weight Loss Does Not Necessarily Mean Failed Metabolic Effects |
Q33608036 | Five-year outcomes of laparoscopic sleeve gastrectomy as a primary procedure for morbid obesity: A prospective study |
Q35630856 | Foregut exclusion disrupts intestinal glucose sensing and alters portal nutrient and hormonal milieu |
Q41078463 | Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test |
Q38307449 | GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery? |
Q52916575 | Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat. |
Q36784428 | Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial |
Q50956202 | Gastrin Secretion After Bariatric Surgery-Response to a Protein-Rich Mixed Meal Following Roux-En-Y Gastric Bypass and Sleeve Gastrectomy: a Pilot Study in Normoglycemic Women. |
Q33464423 | Gastro-intestinal Quality of Life After Metabolic Surgery for the Treatment of Type 2 Diabetes Mellitus |
Q35994552 | Gastrointestinal traits: individualizing therapy for obesity with drugs and devices |
Q33624161 | Gastropleural fistula after single anastomosis gastric bypass. A case report and review of the literature |
Q89978484 | Global Mapping of Interventions to Improve Quality of Life of People with Diabetes in 1990-2018 |
Q47249342 | Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect |
Q48372455 | Glycemic Control after Sleeve Gastrectomy and Roux-En-Y Gastric Bypass in Obese Subjects with Type 2 Diabetes Mellitus. |
Q47935352 | Glycemic control after metabolic surgery: a Granger causality and graph analysis |
Q30235568 | Gut-Brain Cross-Talk in Metabolic Control |
Q48013884 | Health-Related Quality of Life after Bariatric Surgery and its Correlation with Glycaemic Status in Hong Kong Chinese Adults |
Q52770258 | Heterogeneity of proliferative markers in pancreatic β-cells of patients with severe hypoglycemia following Roux-en-Y gastric bypass. |
Q38559029 | How Durable Are the Effects After Metabolic Surgery? |
Q26741527 | How do patients' clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure? |
Q50180316 | How safe is metabolic/diabetes surgery? |
Q47192153 | Hypertension in Obesity and the Impact of Weight Loss |
Q35902704 | Hypovitaminosis D in bariatric surgery: A systematic review of observational studies |
Q38291812 | IFN-γ secretion in gut of Ob/Ob mice after vertical sleeve gastrectomy and its function in weight loss mechanism |
Q48223445 | Identifying Barriers to Appropriate Use of Metabolic/Bariatric Surgery for Type 2 Diabetes Treatment: Policy Lab Results. |
Q38263804 | Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability |
Q48198369 | Immediate Metabolic Response Following Sleeve Gastrectomy in Obese Diabetics. |
Q38720579 | Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis |
Q41043481 | Impact of sleeve gastrectomy verses sleeve gastrectomy plus side-to-side jejunoileal anastomosis on weight loss and metabolic control in an obese rat model. |
Q85410715 | Improvement in severe pulmonary hypertension in obese patients after laparoscopic gastric bypass or sleeve gastrectomy |
Q35012062 | Improvement of diabetes and hypertension after gastrectomy: a nationwide cohort study |
Q38236210 | Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease. |
Q50434312 | Improvements of Glucose and Lipid Metabolism After Jejuno-ileal Circuit Procedure in a Non-obese Diabetic Rat Model |
Q33662245 | Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control. |
Q47289520 | Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). |
Q38580991 | Inpatient Glycemic Protocol for Patients with Diabetes Undergoing Bariatric Surgery. |
Q42502977 | Insulin Sensitivity and Secretion in Obese Type 2 Diabetic Women after Various Bariatric Operations |
Q36830607 | Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents |
Q28072225 | Interaction of obesity and inflammatory bowel disease |
Q47977321 | Iron-Deficiency Anemia After Laparoscopic Roux-en-Y Gastric Bypass in Chinese Obese Patients with Type 2 Diabetes: a 2-Year Follow-Up Study |
Q36686998 | Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease? |
Q47731656 | Is Mini-Gastric Bypass a Rational Approach for Type-2 Diabetes? |
Q94476043 | Is Roux-en-Y gastric bypass advantageous?-surgical outcomes in obese patients with type-2 diabetes after gastric bypass versus sleeve gastrectomy, a matched retrospective study |
Q51297760 | Is a Simple Food-Diverting Operation the Solution for Type 2 Diabetes Treatment? Experimental Study in a Non-Obese Rat Model. |
Q55069710 | Japanese Clinical Practice Guideline for Diabetes 2016. |
Q40632431 | LAP-BAND for BMI 30-40: 5-year health outcomes from the multicenter pivotal study |
Q92025285 | Laparoendoscopic Single-Site Bariatric Surgery: A Review of Single-Port Laparoscopic and Endoscopic Bariatric Treatments |
Q48255876 | Laparoscopic Roux-En-Y Gastric Bypass Improves Lipid Profile and Decreases Cardiovascular Risk: a 5-Year Longitudinal Cohort Study of 1048 Patients |
Q38576004 | Laparoscopic Roux-en-Y gastric bypass patients have an increased lifetime risk of repeat operations when compared to laparoscopic sleeve gastrectomy patients |
Q33717458 | Laparoscopic Roux-en-Y gastric bypass versus laparoscopic mini gastric bypass in the treatment of obesity: study protocol for a randomized controlled trial |
Q37634009 | Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS). |
Q38707776 | Laparoscopic Sleeve Gastrectomy for the Management of Type 1 Diabetes Mellitus. |
Q40517387 | Laparoscopic gastric bypass surgery: a safe and effective operation for the ≥60s? |
Q41530753 | Laparoscopic hand-sewn revisional gastrojejunal plication for weight loss failure after Roux-en-Y gastric bypass |
Q26784214 | Laparoscopic sleeve gastrectomy and gastroesophageal reflux |
Q37409953 | Laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus type 2 patients-single center early experience. |
Q88155293 | Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect |
Q26778002 | Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure? |
Q37591734 | Late presentation of fatal hyperammonemic encephalopathy after Roux-en-Y gastric bypass |
Q36131813 | Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice |
Q36028309 | Leptin deficient ob/ob mice and diet-induced obese mice responded differently to Roux-en-Y bypass surgery |
Q35109151 | Lifestyle and diet |
Q38241747 | Lifestyle management for enhancing outcomes after bariatric surgery. |
Q53144975 | Lithium toxicity after Roux-en-Y bariatric surgery. |
Q35783949 | Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology |
Q47661409 | Long-Term (over 10 Years) Retrospective Follow-up of Laparoscopic Adjustable Gastric Banding. |
Q89670008 | Long-Term (over 13 Years) Follow-Up of Vertical Band Gastroplasty |
Q54314693 | Long-Term Outcomes of Three Types of Bariatric Surgery on Obesity and Type 2 Diabetes Control and Remission. |
Q47136824 | Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery |
Q87934555 | Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy |
Q41862134 | Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery. |
Q35704093 | Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2). |
Q38705488 | Long-term follow-up after bariatric surgery in a national cohort |
Q38753187 | Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study |
Q49850570 | Long-term outcomes of patients undergoing simultaneous Liver Transplantation and Sleeve Gastrectomy. |
Q38880154 | Long-term pharmacotherapy considerations in the bariatric surgery patient |
Q37550281 | Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery |
Q41949952 | Low carbohydrate diet-based intervention for obstructive sleep apnea and primary hypothyroidism in an obese Japanese man. |
Q26784112 | MANAGEMENT OF ENDOCRINE DISEASE: Metabolic effects of bariatric surgery |
Q37339631 | MASTICATORY FUNCTION OF OBESE CANDIDATES TO BARIATRIC SURGERY FROM DISTINCT SOCIOECONOMIC CLASSES. |
Q38389493 | MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose SM vs. Medical Therapy |
Q58617966 | MRI assessment of changes in adipose tissue parameters after bariatric surgery |
Q57026285 | Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) |
Q40236660 | Management of Type 2 Diabetes in the Setting of Morbid Obesity: How Can Weight Gain Be Prevented or Reversed? |
Q56979722 | Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) |
Q34513665 | Management of obesity |
Q34106367 | Managing overweight and obesity in adults to reduce cardiovascular disease risk |
Q37212797 | Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe |
Q57119456 | Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different |
Q34898952 | Mechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery |
Q30238940 | Medical Management of Diabesity: Do We Have Realistic Targets? |
Q41485058 | Medium-Term Results of Laparoscopic Sleeve Gastrectomy: a Matched Comparison with Gastric Bypass |
Q36132127 | Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus |
Q57116100 | Metabolic Surgery and Diabesity: a Systematic Review |
Q48018388 | Metabolic Surgery for Diabetes Treatment: Sleeve Gastrectomy or Gastric Bypass? |
Q28069918 | Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia |
Q36930263 | Metabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care |
Q57117141 | Metabolic Surgery for the Treatment of Diabetes Mellitus Positioning of Leading Medical Associations in Mexico |
Q38572963 | Metabolic Surgery in Type 2 Diabetes: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy as Procedure of Choice? |
Q51841828 | Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations. |
Q90680826 | Metabolic and Endocrine Consequences of Bariatric Surgery |
Q34471033 | Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective |
Q91445282 | Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes |
Q39369814 | Micronutrient Deficiencies After Bariatric Surgery: An Emphasis on Vitamins and Trace Minerals [Formula: see text]. |
Q90010138 | Micronutrient Deficiencies After Roux-en-Y Gastric Bypass: Long-Term Results |
Q37598327 | Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial |
Q39680433 | Mid-Term Remission of Type 2 Diabetes Mellitus After Laparoscopic Roux En-Y Gastric Bypass. |
Q39022546 | Milestone Weight Loss Goals (Weight Normalization and Remission of Obesity) after Gastric Bypass Surgery: Long-Term Results from the University of Michigan |
Q35140176 | Mini-gastric bypass to control morbid obesity and diabetes mellitus: what radiologists need to know |
Q91179582 | Mitochondrial dynamics in skeletal muscle insulin resistance and type 2 diabetes |
Q38249884 | Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit |
Q33600478 | Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice |
Q90352316 | Mortality after bariatric surgery: findings from a 7-year multicenter cohort study |
Q33600044 | National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m2). |
Q36624963 | Nationwide Survey on Bariatric and Metabolic Surgery in Korea: 2003-2013 Results |
Q57114860 | New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis |
Q38211754 | New pharmacological treatments for the management of obesity |
Q90304117 | No Difference in Ghrelin-Producing Cell Expression in Obese Versus Non-obese Stomach: a Prospective Histopathological Case-Control Study |
Q57822734 | Non-pharmacological Treatment Options in the Management of Diabetes Mellitus |
Q38259507 | Novel therapeutics for type 2 diabetes: insulin resistance |
Q88317935 | Obesity |
Q57673205 | Obesity and Type 2 Diabetes |
Q26784097 | Obesity and liver transplantation |
Q37604957 | Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry |
Q30249819 | Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. |
Q48698019 | Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment |
Q38514840 | Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones |
Q92497883 | Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity |
Q49360043 | Optimisation of follow-up after metabolic surgery |
Q37429182 | Outcomes associated with preoperative weight loss after laparoscopic Roux-en-Y gastric bypass |
Q58608335 | Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials |
Q46335474 | Outcomes of One Anastomosis Gastric Bypass in 472 Diabetic Patients |
Q51315185 | Outcomes of bariatric surgery in type 2 diabetic patients with diminished pancreatic secretory reserve. |
Q42697143 | Partitioning of adipose lipid metabolism by altered expression and function of PPAR isoforms after bariatric surgery |
Q39154018 | Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension |
Q27692586 | Patient and Referring Practitioner Characteristics Associated With the Likelihood of Undergoing Bariatric Surgery: A Systematic Review |
Q45326265 | Patient predictors of weight loss following a behavioral weight management intervention among US Veterans with severe obesity. |
Q58447132 | Patient profiling for success after weight loss surgery (GO Bypass study): An interdisciplinary study protocol |
Q90183863 | Patient-reported outcomes for heart failure with preserved ejection fraction: conducting quality studies on quality of life |
Q47549919 | Patient-reported quality of life after bariatric surgery: a single institution analysis. |
Q46832065 | Patterns of Weight Loss Response Following Gastric Bypass and Sleeve Gastrectomy |
Q30241654 | Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children |
Q102369352 | Peri-operative antibiotics acutely and significantly impact intestinal microbiota following bariatric surgery |
Q38734496 | Perioperative Glycemic Management of Patients Undergoing Bariatric Surgery |
Q48100757 | Perioperative Short-Term Outcome in Super-Super-Obese Patients Undergoing Bariatric Surgery. |
Q35204654 | Peripheral mechanisms in appetite regulation |
Q38965089 | Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution? |
Q30374407 | Pleiotropic effects of type 2 diabetes management strategies on renal risk factors. |
Q47915318 | Polycystic ovary syndrome throughout a woman's life |
Q53602917 | Postoperative Outcomes of Laparoscopic Bariatric Surgery in Older Obese Patients: a Matched Case-Control Study. |
Q47184395 | Postoperative Outcomes, Weight Loss Predictors, and Late Gastrointestinal Symptoms Following Laparoscopic Sleeve Gastrectomy |
Q57470802 | Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes |
Q38363114 | Potential mechanisms mediating improved glycemic control after bariatric/metabolic surgery |
Q38232790 | Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control |
Q37683234 | Prediction Model for Hemorrhagic Complications after Laparoscopic Sleeve Gastrectomy: Development of SLEEVE BLEED Calculator. |
Q38552984 | Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass. |
Q92025427 | Prediction of Type 2 Diabetes Remission after Bariatric or Metabolic Surgery |
Q48220785 | Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication |
Q90254057 | Predictive factors for diabetes remission after bariatric surgery |
Q35816567 | Predictors of Postoperative Aftercare Attrition among Gastric Bypass Patients |
Q41117540 | Predictors of long-term diabetes remission after metabolic surgery |
Q99551273 | Predictors of normalized HbA1c after gastric bypass surgery in subjects with abnormal glucose levels, a 2-year follow-up study |
Q40606981 | Predictors of readmission after laparoscopic gastric bypass and sleeve gastrectomy: a comparative analysis of ACS-NSQIP database |
Q95558388 | Preoperative Prediction of Type 2 Diabetes Remission After Gastric Bypass Surgery: a Comparison of DiaRem Scores and ABCD Scores |
Q58447498 | Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery |
Q89816434 | Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model |
Q40050350 | Prevalence and Trends in Lifetime Obesity in the U.S., 1988-2014. |
Q92988144 | Prevalence of hypoglycaemia in a random population after Roux-en-Y gastric bypass after a meal test |
Q50055665 | Quality indicators for metabolic and bariatric surgery in Germany : Evidence-based development of an indicator panel for the quality of results, indications and structure |
Q88112470 | Quality of Life After Bariatric Surgery |
Q47222630 | RYGB Produces more Sustained Body Weight Loss and Improvement of Glycemic Control Compared with VSG in the Diet-Induced Obese Mouse Model. |
Q36505804 | RYGB progressively increases avidity for a low-energy, artificially sweetened diet in female rats |
Q92647262 | Randomized clinical trial of an enhanced recovery after surgery programme versus conventional care in laparoscopic Roux-en-Y gastric bypass surgery |
Q37633938 | Recent Trends in Endoscopic Bariatric Therapies |
Q28083094 | Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence |
Q26745203 | Recent advances in metabolic and bariatric surgery |
Q38849378 | Recent advances in the modification of taste and food preferences following bariatric surgery. |
Q38811941 | Reconciliation of Type 2 Diabetes Remission Rates in Studies of Roux-en-Y Gastric Bypass |
Q38950084 | Reduced inflammatory responses of follicular helper T cell promote the development of regulatory B cells after Roux-en-Y gastric bypass |
Q38607538 | Reduction of Framingham BMI score after rapid weight loss in severely obese subjects undergoing sleeve gastrectomy: a single institution experience |
Q88799890 | Relationship Between Vitamin D Deficiency and the Components of Metabolic Syndrome in Patients with Morbid Obesity, Before and 1 Year After Laparoscopic Roux-en-Y Gastric Bypass or Sleeve Gastrectomy |
Q27022123 | Relationship between gut hormones and glucose homeostasis after bariatric surgery |
Q93078585 | Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: Fact or Fiction? |
Q38263768 | Remission of type 2 diabetes: is bariatric surgery ready for prime time? |
Q37595227 | Renal Function in Type 2 Diabetes Following Gastric Bypass |
Q40534235 | Reproductive Outcomes Differ Following Roux-en-Y Gastric Bypass and Adjustable Gastric Band Compared with Those of an Obese Non-Surgical Group |
Q57108067 | Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment |
Q41171964 | Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery |
Q38843488 | Revisional Bariatric/Metabolic Surgery: What Dictates Its Indications? |
Q41026213 | Risk of Malnutrition, Trace Metal, and Vitamin Deficiency Post Roux-en-Y Gastric Bypass--a Prospective Study of 20 Patients with BMI < 35 kg/m². |
Q57808816 | Risk of Suicide and Self-harm Is Increased After Bariatric Surgery-a Systematic Review and Meta-analysis |
Q37033642 | Risk of post-gastric bypass surgery hypoglycemia in nondiabetic individuals: A single center experience |
Q39256982 | Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. |
Q37639656 | Role of the Gut on Glucose Homeostasis: Lesson Learned from Metabolic Surgery |
Q37188048 | Roux-En Y Gastric Bypass Results in Long-Term Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis. |
Q47821671 | Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis. |
Q37206402 | Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
Q35771371 | Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial |
Q37278829 | Roux-en-Y gastric bypass surgery is effective in fibroblast growth factor-21 deficient mice. |
Q33923792 | STAMPEDE: Bariatric surgery gains more evidence based support |
Q40489457 | Safety analysis of primary bariatric surgery in patients on chronic dialysis |
Q47581286 | Safety and Effectiveness of an Endoscopically Placed Duodenal-Jejunal Bypass Device (EndoBarrier®): Outcomes in 114 Patients |
Q88634575 | Selection of Bypass vs Sleeve for the Management of Type-2 Diabetes in Severely Obese: Could Ethnicity Play a Role? |
Q40093246 | Self-harm and suicide after bariatric surgery: time for action |
Q57062777 | Serum FABP4 concentrations decrease after Roux-en-Y gastric bypass but not after intensive medical management |
Q45539867 | Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study |
Q38973619 | Signals from the gut microbiota to distant organs in physiology and disease |
Q36550718 | Simplified gastric bypass: 13 years of experience and 12,000 patients operated |
Q89643061 | Single Anastomosis Duodenal Switch: 1-Year Outcomes |
Q50051028 | Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-world Population |
Q38912733 | Single-Anastomosis Pylorus-Preserving Bariatric Procedures: Review of the Literature. |
Q64956935 | Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a pro |
Q47356519 | Sleeve Gastrectomy Decreases Body Weight, Whole-Body Adiposity, and Blood Pressure Even in Aged Diet-Induced Obese Rats |
Q35832855 | Sleeve Gastrectomy Does Not Cause Hypertrophy and Reprogramming of Intestinal Glucose Metabolism in Rats |
Q47620617 | Sleeve Gastrectomy Outcomes in Patients with BMI Between 30 and 35-3 Years of Follow-Up |
Q47356999 | Sleeve Gastrectomy Reduces Body Weight and Improves Metabolic Profile also in Obesity-Prone Rats. |
Q88742473 | Sleeve Gastrectomy and Diabetes: Is Cure Possible? |
Q89758359 | Sleeve Gastrectomy enhances glucose utilization and remodels adipose tissue independent of weight loss |
Q64066317 | Sleeve gastrectomy rapidly enhances islet function independently of body weight |
Q51301524 | Sleeve gastrectomy, but not duodenojejunostomy, preserves total beta-cell mass in Goto-Kakizaki rats evaluated by three-dimensional optical projection tomography. |
Q90627250 | Stapler-Less Robotic Partial Gastrectomy: a Safety and Feasibility Experimental Study |
Q50231226 | Stigma and Knowledge as Determinants of Recommendation and Referral Behavior of General Practitioners and Internists |
Q47285702 | Structured dietary intervention to facilitate weight loss after bariatric surgery: A randomized, controlled pilot study |
Q38990059 | Successful Treatment of an Unusual Case of FPLD2: The Role of Roux-en-Y Gastric Bypass-Case Report and Literature Review. |
Q38333573 | Surgery in the treatment of type 2 diabetes mellitus. |
Q39030273 | Surgical Treatment of Metabolic Syndrome |
Q42329519 | Surgical Treatment of Type 2 Diabetes |
Q54438990 | Surgical advances in obese candidates and recipients. |
Q51263392 | Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese Patients: a Short-Term Outcome. |
Q30372129 | Surgical models of Roux-en-Y gastric bypass surgery and sleeve gastrectomy in rats and mice. |
Q89109805 | Surgical treatment of obesity |
Q38394137 | Surgical treatment of obesity: status quo |
Q42928733 | Sympathetic inhibition after bariatric surgery |
Q33907979 | TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice |
Q92431618 | THE INFLUENCE OF TOTAL OR SUB-TOTAL GASTRECTOMY ON GLUCOSE CONTROL IN DIABETIC AND NON-DIABETIC PATIENTS |
Q37339623 | THE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I AND TYPE 2 DIABETES NOT CONTROLLED CLINICALLY. |
Q38894976 | THE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I ANDCLINICALLY UNCONTROLLED TYPE 2 DIABETES. |
Q49304849 | THE ROLE OF THE SLEEVE GASTRECTOMY AND THE MANAGEMENT OF TYPE 2 DIABETES. |
Q90654965 | Taste Changes after Bariatric Surgery: a Systematic Review |
Q35577851 | Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. |
Q92046689 | Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control |
Q46358203 | Ten-year Outcomes of a Prospective Randomized Trial of Laparoscopic Gastric Bypass Versus Laparoscopic Gastric Banding |
Q51306390 | The 10(th) Annual Cardiometabolic Health Congress General Session Highlights. |
Q38910283 | The Bariatric Patient in the Intensive Care Unit: Pitfalls and Management |
Q50644121 | The Diabetes Surgery Summit II Guidelines: a Disease-Based Clinical Recommendation. |
Q28075888 | The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both? |
Q40922935 | The Effect of Weight Loss on Indigenous Australians with Diabetes: a study of Feasibility, Acceptability and Effectiveness of Laparoscopic Adjustable Gastric Banding. |
Q89127173 | The Effectiveness of Endoscopic Gastroplasty for Obesity Treatment According to FDA Thresholds: Systematic Review and Meta-Analysis Based on Randomized Controlled Trials |
Q48139356 | The IGF-Axis and Diabetic Retinopathy Before and After Gastric Bypass Surgery |
Q36177694 | The Newfoundland and Labrador Bariatric Surgery Cohort Study: Rational and Study Protocol |
Q53770143 | The Parabrachial Nucleus: CGRP Neurons Function as a General Alarm. |
Q30249489 | The Role of Metabolic Surgery on Blood Pressure Control |
Q33889594 | The Role of Sleeve Gastrectomy on Preventing Type 2 Diabetes Mellitus |
Q36388487 | The Role of the Multidisciplinary Conference in the Evaluation of Bariatric Surgery Candidates with a High-Risk Psychiatric Profile |
Q37359266 | The Saudi clinical practice guideline for the management of overweight and obesity in adults. |
Q53438835 | The Science of Obesity Management: An Endocrine Society Scientific Statement. |
Q35698046 | The Short-Term Remission of Diabetic Nephropathy After Roux-en-Y Gastric Bypass in Chinese Patients of T2DM with Obesity |
Q47755685 | The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass |
Q36032611 | The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials |
Q38745483 | The contribution of rising adiposity to the increasing prevalence of diabetes in the United States |
Q26783535 | The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones |
Q47352216 | The effects of diet- and RYGB-induced weight loss on insulin sensitivity in obese patients with and without type 2 diabetes |
Q87983913 | The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery |
Q39435137 | The essential role of exercise in the management of type 2 diabetes. |
Q37074338 | The evolving role of bariatric surgery in patients with type 1 diabetes and obesity |
Q38793359 | The future of the Roux-en-Y gastric bypass |
Q35376124 | The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence |
Q38924361 | The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance |
Q26767142 | The metabolic vascular syndrome - guide to an individualized treatment |
Q35043446 | The physiology underlying Roux-en-Y gastric bypass: a status report |
Q38709454 | The risk of kidney stones following bariatric surgery: a systematic review and meta-analysis |
Q41363406 | The role of bariatric surgery to treat diabetes: current challenges and perspectives |
Q35665486 | The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. |
Q86969104 | The rollercoaster of post-bariatric hypoglycaemia |
Q39512020 | The safety of laparoscopic sleeve gastrectomy among diabetic patients. |
Q36998556 | Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial |
Q47896663 | Thrombin Generation Measurements in Patients Scheduled for Laparoscopic Bariatric Surgery |
Q48778308 | Top 10 cardiovascular therapies and interventions for the next decade |
Q52573286 | Totally endoscopic implant to effect a gastric bypass: 12-month safety and efficacy outcomes. |
Q36956145 | Treatment of Obesity: Weight Loss and Bariatric Surgery |
Q37110293 | Type 1 Diabetes Mellitus and Bariatric Surgery: A Systematic Review and Meta-Analysis |
Q37025587 | Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study |
Q48233341 | Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m(2) using strict remission criteria: early outcomes of a prospective study among Mexicans |
Q46364544 | Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. |
Q30276811 | Type 2 diabetes remission following gastric bypass: does diarem stand the test of time? |
Q53535466 | Type 2 diabetes: multimodal treatment of a complex disease. |
Q59795202 | Understanding the psychosocial impact of weight loss following bariatric surgery: a qualitative study |
Q55004158 | Unraveling the compromised biomechanical performance of type 2 diabetes- and Roux-en-Y gastric bypass bone by linking mechanical-structural and physico-chemical properties. |
Q38840514 | Use of Home Parenteral Nutrition in Post-Bariatric Surgery-Related Malnutrition |
Q57797785 | Using the Minnesota Multiphasic Personality Inventory-2-Restructured Form Cutoffs to Predict Lack of Pre-surgical Exercise |
Q34475450 | Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats |
Q24186730 | Vitamin D supplementation for obese adults undergoing bariatric surgery |
Q88261815 | Weight Loss and Comorbidity Resolution 3 Years After Bariatric Surgery-an Indian Perspective |
Q36736117 | Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents |
Q34503739 | Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action |
Q41698360 | Weight regain after Roux-en-Y gastric bypass has a large negative impact on the Bariatric Quality of Life Index. |
Q55555487 | What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism? |
Q38655873 | What is the Mechanism Behind Weight Loss Maintenance with Gastric Bypass? |
Q39067032 | What is the role of bariatric surgery in the management of obesity? |
Q85786867 | [Clinical evidence for metabolic surgery] |
Q85499934 | [Dumping syndrome: Diagnostics and therapeutic options] |
Q53077298 | [Endoscopic treatment of obesity and complications following bariatric surgery]. |
Q85815704 | [Insulin or surgery? : the perspective of a diabetologist] |
Q52786916 | [Metabolic surgery or conservative measures as therapy of obese type 2 diabetics?] |
Q86629823 | [Pharmacological therapy versus bariatric surgery for patients with obesity and type 2 diabetes] |
Q52872871 | [Procedure selection and technique of metabolic surgery]. |
Q53062719 | [Redo intervention and complication management in bariatric surgery]. |
Q27692665 | β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes |
Q48243935 | γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery. |
Search more.